PMID- 27525523 OWN - NLM STAT- MEDLINE DCOM- 20170810 LR - 20231213 IS - 1546-170X (Electronic) IS - 1078-8956 (Linking) VI - 22 IP - 9 DP - 2016 Sep TI - Identification of a major epitope by anti-interferon-gamma autoantibodies in patients with mycobacterial disease. PG - 994-1001 LID - 10.1038/nm.4158 [doi] AB - The binding of autoantibodies (autoAbs) to interferon (IFN)-gamma in people with mycobacterial diseases has become an emerging medical concern. Many patients display specific human leukocyte antigen (HLA) class II haplotypes, which suggests that a common T cell-dependent and B cell-dependent mechanism might underlie the production of specific anti-IFN-gamma autoAbs. We show here that these autoAbs target a major epitope (amino acids 121-131, designated position (P)121-131) in a region crucial for IFN-gamma receptor (IFN-gammaR) activation to impair IFN-gamma-mediated activities. The amino acid sequence of this epitope is highly homologous to a stretch in the Noc2 protein of Aspergillus spp., which was cross-reactive with autoAbs from patients. Rats immunized with Aspergillus Noc2 developed antibodies that reacted with human IFN-gamma. We generated an epitope-erased variant of IFN-gamma (EE-IFN-gamma), in which the major neutralizing epitope region was altered. The binding affinity of anti-IFN-gamma autoAbs for EE-IFN-gamma was reduced by about 40%, as compared to that for IFN-gamma1-131. Moreover, EE-IFN-gamma activated the IFN-gammaR downstream signaling pathway ex vivo, irrespectively of anti-IFN-gamma autoAbs. In conclusion, we identified a common, crucial B cell epitope that bound to anti-IFN-gamma autoAbs in patients, and we propose a molecular-mimicry model for autoAb development. In addition, treatment with EE-IFN-gamma might be worth investigating in patients producing anti-IFN-gamma autoAbs. FAU - Lin, Chia-Hao AU - Lin CH AD - Laboratory of Human Immunology and Infectious Diseases, Graduate Institute of Clinical Medical Sciences, Chang Gung University, Taoyuan, Taiwan. AD - Graduate Institute of Biomedical Sciences, Chang Gung University, Taoyuan, Taiwan. FAU - Chi, Chih-Yu AU - Chi CY AD - Laboratory of Human Immunology and Infectious Diseases, Graduate Institute of Clinical Medical Sciences, Chang Gung University, Taoyuan, Taiwan. AD - Division of Infectious Diseases, Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan. AD - School of Medicine, College of Medicine, China Medical University, Taichung, Taiwan. FAU - Shih, Han-Po AU - Shih HP AD - Laboratory of Human Immunology and Infectious Diseases, Graduate Institute of Clinical Medical Sciences, Chang Gung University, Taoyuan, Taiwan. FAU - Ding, Jing-Ya AU - Ding JY AD - Laboratory of Human Immunology and Infectious Diseases, Graduate Institute of Clinical Medical Sciences, Chang Gung University, Taoyuan, Taiwan. FAU - Lo, Chia-Chi AU - Lo CC AD - Laboratory of Human Immunology and Infectious Diseases, Graduate Institute of Clinical Medical Sciences, Chang Gung University, Taoyuan, Taiwan. FAU - Wang, Shang-Yu AU - Wang SY AD - Laboratory of Human Immunology and Infectious Diseases, Graduate Institute of Clinical Medical Sciences, Chang Gung University, Taoyuan, Taiwan. AD - Division of Trauma and Emergency Surgery, Department of General Surgery, Chang Gung Memorial Hospital, Taoyuan, Taiwan. FAU - Kuo, Chen-Yen AU - Kuo CY AD - Laboratory of Human Immunology and Infectious Diseases, Graduate Institute of Clinical Medical Sciences, Chang Gung University, Taoyuan, Taiwan. AD - Division of Infectious Diseases, Department of Pediatrics, Chang Gung Memorial Hospital, Taoyuan, Taiwan. FAU - Yeh, Chun-Fu AU - Yeh CF AD - Laboratory of Human Immunology and Infectious Diseases, Graduate Institute of Clinical Medical Sciences, Chang Gung University, Taoyuan, Taiwan. AD - Division of Infectious Diseases, Department of Internal Medicine, Chang Gung Memorial Hospital, Taoyuan, Taiwan. AD - Chang Gung University College of Medicine, Taoyuan, Taiwan. FAU - Tu, Kun-Hua AU - Tu KH AD - Laboratory of Human Immunology and Infectious Diseases, Graduate Institute of Clinical Medical Sciences, Chang Gung University, Taoyuan, Taiwan. AD - Chang Gung University College of Medicine, Taoyuan, Taiwan. AD - Kidney Research Center, Department of Nephrology, Chang Gung Memorial Hospital, Taipei, Taiwan. FAU - Liu, Shou-Hsuan AU - Liu SH AD - Laboratory of Human Immunology and Infectious Diseases, Graduate Institute of Clinical Medical Sciences, Chang Gung University, Taoyuan, Taiwan. AD - Chang Gung University College of Medicine, Taoyuan, Taiwan. AD - Kidney Research Center, Department of Nephrology, Chang Gung Memorial Hospital, Taipei, Taiwan. FAU - Chen, Hung-Kai AU - Chen HK AD - Laboratory of Translational Medicine, Development Center for Biotechnology, New Taipei City, Taiwan. FAU - Ho, Chen-Hsuan AU - Ho CH AD - Laboratory of Translational Medicine, Development Center for Biotechnology, New Taipei City, Taiwan. FAU - Ho, Mao-Wang AU - Ho MW AD - Division of Infectious Diseases, Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan. FAU - Lee, Chen-Hsiang AU - Lee CH AD - Division of Infectious Diseases, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan. FAU - Lai, Hsin-Chin AU - Lai HC AD - Graduate Institute of Biomedical Sciences, Chang Gung University, Taoyuan, Taiwan. AD - Chang Gung Immunology Consortium, Chang Gung Memorial Hospital and Chang Gung University, Taoyuan, Taiwan. FAU - Ku, Cheng-Lung AU - Ku CL AD - Laboratory of Human Immunology and Infectious Diseases, Graduate Institute of Clinical Medical Sciences, Chang Gung University, Taoyuan, Taiwan. AD - Division of Infectious Diseases, Department of Internal Medicine, Chang Gung Memorial Hospital, Taoyuan, Taiwan. AD - Chang Gung Immunology Consortium, Chang Gung Memorial Hospital and Chang Gung University, Taoyuan, Taiwan. AD - Graduate Institute of Clinical Medical Science, China Medical University, Taichung, Taiwan. LA - eng PT - Journal Article DEP - 20160815 PL - United States TA - Nat Med JT - Nature medicine JID - 9502015 RN - 0 (Antibodies, Neutralizing) RN - 0 (Autoantibodies) RN - 0 (Autoantigens) RN - 0 (Epitopes) RN - 0 (Epitopes, B-Lymphocyte) RN - 0 (Fungal Proteins) RN - 0 (HLA-DR Antigens) RN - 0 (Histocompatibility Antigens Class II) RN - 0 (Interleukin-12 Subunit p40) RN - 0 (Receptors, Interferon) RN - 82115-62-6 (Interferon-gamma) SB - IM CIN - Nat Med. 2016 Sep 7;22(9):973-5. PMID: 27603131 MH - Animals MH - Antibodies, Neutralizing/*immunology MH - Aspergillus MH - Autoantibodies/*immunology MH - Autoantigens/immunology MH - Case-Control Studies MH - Cross Reactions MH - Enzyme-Linked Immunosorbent Assay MH - Epitope Mapping MH - Epitopes/*immunology MH - Epitopes, B-Lymphocyte MH - Fungal Proteins/immunology MH - HLA-DR Antigens/immunology MH - Haplotypes MH - Histocompatibility Antigens Class II/genetics MH - Humans MH - Immunization MH - Immunoblotting MH - Interferon-gamma/*immunology MH - Interleukin-12 Subunit p40/immunology MH - Mycobacterium Infections MH - Rats MH - Receptors, Interferon/immunology MH - Interferon gamma Receptor EDAT- 2016/08/16 06:00 MHDA- 2017/08/11 06:00 CRDT- 2016/08/16 06:00 PHST- 2016/03/22 00:00 [received] PHST- 2016/07/01 00:00 [accepted] PHST- 2016/08/16 06:00 [entrez] PHST- 2016/08/16 06:00 [pubmed] PHST- 2017/08/11 06:00 [medline] AID - nm.4158 [pii] AID - 10.1038/nm.4158 [doi] PST - ppublish SO - Nat Med. 2016 Sep;22(9):994-1001. doi: 10.1038/nm.4158. Epub 2016 Aug 15.